


| Key | % Net Assets |
|---|---|
| 13.6% | |
| 10.4% | |
| 8.8% | |
| 7.2% | |
| 60% |
| Name | % Net Assets |
|---|---|
| Fisher Scientific | 13.6% |
| Tyco International | 10.4% |
| Gilead Sciences | 8.8% |
| Accenture | 7.2% |
| Biomet | 6.9% |
| C.H. Robinson Worldwide | 6.6% |
| Home Depot | 6.0% |
| Bed Bath & Beyond | 5.8% |
| Allergan | 5.4% |
| L-3 Communications | 4.7% |
No asset data available.
| Date | 15-Aug-2025 |
|---|---|
| Bid | 2.71p |
| Offer | 2.90p |
| Currency | GBP |
| Change | 2.81p |
| % | n/a |
| YTD change | 0.26p |
| YTD % | 10.16% |
| Fund Inception | 01/03/1999 |
|---|---|
| Fund Manager | David Tyerman |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | £10000 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 7.00% |
| Annual Mang't | 1.00% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | -0.00 |
You are here: research